This Article Full Text Full Text (PDF) All Versions of this Article: 2003-0330OCv1 31/1/13    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Powell, R. M. Articles by Davies, D. E. Search for Related Content PubMed PubMed Citation Articles by Powell, R. M. Articles by Davies, D. E.

The Splicing and Fate of ADAM33 Transcripts in Primary Human Airways Fibroblasts

Brooke Laboratories, Division of Infection, Inflammation and Repair, School of Medicine, Southampton General Hospital, Southampton, United Kingdom

Address correspondence to: Robert M. Powell, The Brooke Laboratories, Level F, South Mailpoint 888, Southampton General Hospital, Southampton SO16 6YD, UK. E-mail: R.M.Powell{at}soton.ac.uk

The ADAM (A Disintegrin and Metalloprotease) family of Zn⁺⁺-dependent metalloproteases are multidomain proteins involved in diverse cellular activities. Polymorphic variation in ADAM33 is strongly associated with asthma and bronchial hyperresponsiveness. Identification of those isoforms of ADAM33 that are expressed in airways is fundamental to dissecting the role of ADAM33 in asthma. Analysis of primary human airways fibroblasts has shown the presence of a number of alternatively spliced forms of ADAM33, including one encoding a putative secreted variant, and many transcripts lacking the metalloproteinase domain. The relative abundance of these transcripts has been quantified using reverse transcription real-time polymerase chain reaction, in both nuclear and cytoplasmic fractions of RNA. These results demonstrate that a number of splice variants of ADAM33 are transported into the cytoplasm. Ninety percent of ADAM33 mRNA is retained in the nucleus and the subtle differences in the composition of nuclear and cytoplasmic RNA suggest important events in the splicing and selection of ADAM33 transcripts. Western blot analysis confirmed that several protein isoforms of ADAM33 are expressed in primary airways fibroblasts. These findings demonstrate that ADAM33 exists in multiple isoforms, suggesting that it is a complex molecule that plays multiple roles within mesenchymal cells.

Abbreviations: A Disintegrin and Metalloprotease, ADAM • bronchial hyperresponsiveness, BHR • epidermal growth factor, EGF • human airways fibroblasts, HAF • metalloproteinase, MP • polymerase chain reaction, PCR • single nucleotide polymorphism, SNP

This article has been cited by other articles:

				S. T. Holgate, D. E. Davies, R. M. Powell, P. H. Howarth, H. M. Haitchi, and J. W. Holloway Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms Eur. Respir. J., April 1, 2007; 29(4): 793 - 803. [Abstract] [Full Text] [PDF]

				F. Sampsonas, A. Kaparianos, D. Lykouras, K. Karkoulias, and K. Spiropoulos DNA sequence variations of metalloproteinases: their role in asthma and COPD Postgrad. Med. J., April 1, 2007; 83(978): 244 - 250. [Abstract] [Full Text] [PDF]

				S. T. Holgate, Y. Yang, H.-M. Haitchi, R. M. Powell, J. W. Holloway, H. Yoshisue, Y. Y. Pang, J. Cakebread, and D. E. Davies The Genetics of Asthma: ADAM33 as an Example of a Susceptibility Gene. Proceedings of the ATS, July 1, 2006; 3(5): 440 - 443. [Abstract] [Full Text] [PDF]

				J.-Y. Lee, S.-W. Park, H. K. Chang, H. Y. Kim, T. Rhim, J.-H. Lee, A.-S. Jang, E.-S. Koh, and C.-S. Park A Disintegrin and Metalloproteinase 33 Protein in Patients with Asthma: Relevance to Airflow Limitation Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 729 - 735. [Abstract] [Full Text] [PDF]

				C. Boxall, S. T. Holgate, and D. E. Davies The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma Eur. Respir. J., January 1, 2006; 27(1): 208 - 229. [Abstract] [Full Text] [PDF]

				Spoken sessions Thorax, December 1, 2005; 60(suppl_2): ii4 - ii52. [Full Text] [PDF]

				S R Johnson TIMP-1 in asthma: guilty by association Thorax, August 1, 2005; 60(8): 617 - 618. [Full Text] [PDF]

				C. C. van Diemen, D. S. Postma, J. M. Vonk, M. Bruinenberg, J. P. Schouten, and H. M. Boezen A Disintegrin and Metalloprotease 33 Polymorphisms and Lung Function Decline in the General Population Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 329 - 333. [Abstract] [Full Text] [PDF]

				A. Simpson, N. Maniatis, F. Jury, J. A. Cakebread, L. A. Lowe, S. T. Holgate, A. Woodcock, W. E. R. Ollier, A. Collins, A. Custovic, et al. Polymorphisms in A Disintegrin and Metalloprotease 33 (ADAM33) Predict Impaired Early-Life Lung Function Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 55 - 60. [Abstract] [Full Text] [PDF]

				H. M. Haitchi, R. M. Powell, T. J. Shaw, P. H. Howarth, S. J. Wilson, D. I. Wilson, S. T. Holgate, and D. E. Davies ADAM33 Expression in Asthmatic Airways and Human Embryonic Lungs Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 958 - 965. [Abstract] [Full Text] [PDF]

				S T Holgate and J W Holloway Is big beautiful? The continuing story of ADAM33 and asthma Thorax, April 1, 2005; 60(4): 263 - 264. [Full Text] [PDF]

				J Blakey, E Halapi, U S Bjornsdottir, A Wheatley, S Kristinsson, R Upmanyu, K Stefansson, H Hakonarson, and I P Hall Contribution of ADAM33 polymorphisms to the population risk of asthma Thorax, April 1, 2005; 60(4): 274 - 276. [Abstract] [Full Text] [PDF]

				H. Yoshisue, S. M. Puddicombe, S. J. Wilson, H. M. Haitchi, R. M. Powell, D. I. Wilson, A. Pandit, A. E. Berger, D. E. Davies, S. T. Holgate, et al. Characterization of Ciliated Bronchial Epithelium 1, a Ciliated Cell-Associated Gene Induced During Mucociliary Differentiation Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 491 - 500. [Abstract] [Full Text] [PDF]

				B. A. Raby and S. T. Weiss ADAM33: Where Are We Now? Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 1 - 2. [Full Text] [PDF]